Executive summary of the Integrated Clinical care pathway for the detection and management of preclinical stages of type 1 diabetes: SED-SEEN-SEEP consensus.

Authors

Ana Lucía Gómez Gila, Fernando Gómez-Peralta, Susana Pica Montesinos, Virginia Bellido, Roque Cardona-Hernandez, María Asunción Martínez-Brocca

Published in

Endocrinologia, diabetes y nutricion. Pages 501879. Sep 30, 2026. Epub Sep 30, 2026.

Abstract

Type 1 diabetes (T1D) can be identified in preclinical stages through the detection of islet autoantibodies and staged before clinical onset. This evolving paradigm highlights the need for structured care models allowing coordinated identification, staging, and follow-up of individuals with positive islet autoimmunity. This document describes an Integrated Care Pathway (ICP) developed from the available scientific evidence and the national SED-SEEN-SEEP consensus on screening and monitoring of preclinical T1D. The model is organised into three core sub-processes (target population identification, autoantibody detection and confirmation, and clinical follow-up with staging) and one transversal support sub-process based on information systems and performance indicators. This ICP provides a structured, evaluable, and scalable framework for the homogeneous implementation of screening and follow-up of preclinical T1D.

PMID:
42716905
Bibliographic data and abstract were imported from PubMed on 10 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.